Cognizant to Acquire marketRx, a Leading Provider of Life Sciences Market Analytics

Cognizant to Acquire marketRx, a Leading Provider of Life Sciences Market Analytics

October 19, 2007

Strategic acquisition to expand Cognizant's Life Sciences
industry offerings

    TEANECK, N.J., Oct. 19 /Xinhua-PRNewswire/ -- 

    Cognizant Technology Solutions Corporation (Nasdaq:
CTSH), a leading provider of global IT and business process
outsourcing services, today announced that it has signed a
definitive agreement to acquire NJ-based marketRx, Inc., a
leading provider of analytics and related software services
to global Life Sciences companies in the pharmaceutical,
biotechnology and medical devices segments. Cognizant will
pay approximately $135 million in cash, which will be
funded from current cash reserves. 

    This acquisition strengthens Cognizant's full-suite of
offerings across all areas of the Life Sciences value chain
- from Research & Development and Manufacturing to Sales
& Marketing Operations. marketRx combines analytics,
market research and software services to provide scalable,
web-based solutions in three functional areas for Life
Sciences companies: Sales Management & Operations,
Brand Marketing & Product Management and Market
Research. marketRx brings an impressive client base to
Cognizant representing a total of 75 Life Sciences
customers, including all of the largest 20 pharmaceutical
companies and 4 out of the top 5 biotech companies.

    "We welcome the marketRx employees and management
team to Cognizant. This acquisition expands our
capabilities in the analytics segment and broadens our
service offerings for the Life Sciences industry, while
providing strong synergies with our existing Business
Intelligence/Data Warehousing and CRM services," said
Francisco D'Souza, president and CEO, Cognizant.
"marketRx's proven global delivery model for
analytics, deep domain knowledge and proprietary analytics
software platform have helped the Company build an
impressive client list in the Life Sciences market and
yield strong organic growth. We expect to leverage these
assets to establish a pre-eminent position in the
fast-growing analytics market both in Life Sciences and
other industries." 

    "We are very pleased to join the Cognizant family.
The combination of our market leading position in the Life
Sciences analytics segment and Cognizant's strengths as a
top global services player will allow us to expand our
relationships with our Life Sciences clients by providing
them with a broader range of outsourced services, and
conversely enables us to extend our capabilities to other
vertical markets," said Jaswinder (Jassi) Chadha,
founder, president & CEO, marketRx, Inc. "We found
a great cultural fit between both companies in terms of
entrepreneurial spirit, commitments to client satisfaction,
strong client retention record, proven high-touch
onsite/offshore model and overall vision for the future of
the global services industry." 

    Subject to the satisfaction of certain closing
conditions, the transaction is expected to close in the
fourth quarter of 2007. 

    About marketRx

    With over 430 employees in the U.S., India and Europe,
marketRx enables customers at global pharmaceutical and
biotechnology companies to improve the effectiveness of
their sales and marketing operations. Sequoia-backed
marketRx has received many notable industry recognitions
since its inception in 2000 including Deloitte's fastest
growing technology companies in North America for two
consecutive years (2005 and 2006), PwC & Entrepreneur
Magazine's 'Hot 100' fastest growing companies in the U.S.
(2005), Inc. 500's "Fastest Growing 500
companies" (2005) and SiliconIndia Magazine's
"si100 list of Top 100 technology companies formed in
the U.S. by people of Indian origin". 

    About Cognizant

    Cognizant (Nasdaq: CTSH) is a leading provider of
global IT and business process outsourcing services.
Focused on delivering strategic information technology
solutions that address the complex business needs of its
clients, Cognizant uses its own on-site/offshore
outsourcing model to provide applications management,
development, integration, and reengineering, infrastructure
management, business process outsourcing, and numerous
related services, such as enterprise consulting, technology
architecture, program management, and change management. 

    Cognizant has approximately 49,000 employees who are
committed to partnerships that sustain long-term, proven
value for customers by delivering high-quality,
cost-effective solutions through its development centers in
India and on-site client teams. Cognizant maintains P-CMM,
SW-CMM and CMMI Maturity Level 5 assessments from an
independent third-party assessor and ranked among the top
information technology companies in Business Week's Hot
Growth Companies and Forbes Global 2000 list. Cognizant is
a member of the NASDAQ-100 Index and the S&P 500 Index.
Find additional information about Cognizant at
www.cognizant.com.

    Forward-Looking Statements

    This press release includes statements which may
constitute forward-looking statements made pursuant to the
safe harbor provisions of the Private Securities Litigation
Reform Act of 1995, the accuracy of which are necessarily
subject to risks, uncertainties, and assumptions as to
future events that may not prove to be accurate. Factors
that could cause actual results to differ materially from
those expressed or implied include general economic
conditions and the factors discussed in our most recent
Form 10-K and other filings with the Securities and
Exchange Commission. Cognizant undertakes no obligation to
update or revise any forward-looking statements, whether as
a result of new information, future events, or otherwise.


    For more information, please contact:

     Kirsten Paragona, Director, Corporate Media Relations
     Phone: [phone]
     Email: [e-mail]

     Investors, Financial
     Scot Hoffman, Financial Dynamics
     Phone: [phone]
     Email: [e-mail]